(Q34573511)

3 August 2017

1 reference

title

HIV, dementia and antiretroviral drugs: 30 years of an epidemic (English)

1 reference

3 August 2017

main subject

anti-retroviral agent

0 references

0 references

1 reference

3

Alan Winston

1 reference

3 August 2017

Hadi Manji

1

1 reference

3 August 2017

H R Jäger

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 February 2013

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

3 August 2017

published in

1 reference

3 August 2017

volume

84

1 reference

3 August 2017

issue

10

1 reference

3 August 2017

page(s)

1126-1137

1 reference

Updated research nosology for HIV-associated neurocognitive disorders

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

HIV-associated opportunistic infections of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Neurologic abnormalities and recovery of human immunodeficiency virus from cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

The central nervous system as a reservoir for simian immunodeficiency virus (SIV): steady-state levels of SIV DNA in brain from acute through asymptomatic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Neurological and neuropsychological performance in HIV seropositive men without symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Low prevalence of neurological and neuropsychological abnormalities in otherwise healthy HIV-1-infected individuals: results from the multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Neuropathology of early HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection--The Hawaii Aging with HIV Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Human immunodeficiency virus-associated neurocognitive disorder: pathophysiology in relation to drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Host and viral factors influencing the pathogenesis of HIV-associated neurocognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

CCR2 polymorphisms affect neuropsychological impairment in HIV-1-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Neurocognition in individuals co-infected with HIV and hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

HIV-1 clade-specific differences in the induction of neuropathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Neuroimaging in the brain in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

3D pattern of brain atrophy in HIV/AIDS visualized using tensor-based morphometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Multinucleated giant cells in brain: a hallmark of the acquired immune deficiency syndrome (AIDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

The Neuropathology of HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Neuropathology of Human Immunodeficiency Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Neuronal number and volume alterations in the neocortex of HIV infected individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Neurobiological aspects of human immunodeficiency virus infection: neurotoxic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Transient exposure to HIV-1 Tat protein results in cytokine production in macrophages and astrocytes. A hit and run phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/polymerase chain reaction in situ hybridization and immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

HIV dementia: an evolving disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Does highly active antiretroviral therapy improve neurocognitive function? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

The prevalence and incidence of neurocognitive impairment in the HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Relationship of ethnicity, age, education, and reading level to speed and executive function among HIV+ and HIV- women: the Women's Interagency HIV Study (WIHS) Neurocognitive Substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Neurocognitive impairment and HIV risk factors: a reciprocal relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Antiretroviral therapy and central nervous system HIV type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Factors affecting delivery of antiviral drugs to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Pharmacokinetics of lamivudine and BCH-189 in plasma and cerebrospinal fluid of nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Cytological and immunoglobulin findings in cerebrospinal fluid of symptomatic and asymptomatic human immunodeficiency virus (HIV) seropositive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Acute Meningoencephalitis in Chronic Human Immunodeficiency Virus (HIV) Infection: Putative Central Nervous System Escape of HIV Replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

A brief review of potential mechanisms of immune reconstitution inflammatory syndrome in HIV following antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Therapy Insight: CNS manifestations of HIV-associated immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2012-304022

21 January 2018

Identifiers

DOI

10.1136/JNNP-2012-304022

1 reference

3 August 2017

1 reference